| 摘要 |
The present invention provides an effective therapeutic agent for chronic hepatitis C, as well as a drug administration system for treating chronic hepatitis C by use of said therapeutic agent. Specifically, the present invention provides a therapeutic agent for negation of hepatitis C virus (HCV)-RNA wherein the daily effective dosage of interferon (IFN) is administered once per day, or divided and administered in portions per day. The present invention also provides a drug administration system for administering said therapeutic agent, and a method for negation of HCV-RNA by said drug administration system, as well as a therapeutic method for chronic hepatitis C. The IFN is IFN-alpha or IFN-beta.
|
